Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
about
Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control studyComparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort StudyThe quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Risk of severe upper gastrointestinal complications among oral bisphosphonate usersOral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study.Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.Improving medical record retrieval for validation studies in Medicare data.Improving postapproval drug safety surveillance: getting better information soonerPharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions.Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departmentsIncidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country.VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.Potential statin-drug interactions: prevalence and clinical significanceDrug and dietary interactions of warfarin and novel oral anticoagulants: an update.Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study.Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism.Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching.Non-traumatic compartment syndrome secondary to deep vein thrombosis and anticoagulationAnticoagulation for noncardiac indications in neurologic patients: comparative use of non-vitamin k oral anticoagulants, low-molecular-weight heparins, and warfarin.A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele.Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement.The Role of Clinical Variables and VKORC1 Polymorphism in Efficacy and Stability of Acenocoumarol in Neurological Patients.Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore.
P2860
Q28478738-442A6965-F532-4B8E-BFE6-24EE4A114CF2Q28552407-162C03D6-C4E7-4CBB-8D92-90FAF5A0207EQ33608853-B7D45ED2-DA0F-45AA-8698-0055A0A036D4Q34252907-43A2EEE6-23B5-4939-960B-2F62A981E0ABQ35069355-367AF31C-70B1-4B77-8AE4-D55868193BA1Q35084489-05791CD4-E5CB-4CC2-B706-221ACD8701D3Q35126153-41B329F7-8CEF-4FDC-8E8B-DD01998C0F81Q36011053-66DF2C07-D461-49E8-A159-5CDF0E47D443Q36333473-52B8B1B1-0539-446F-BFAA-F350C10E0FFDQ36367834-B262F07A-FA36-4C91-82CE-8B61CC6D184FQ36483976-CD0745CD-EE6D-420C-B759-CA05D5235B85Q36785642-4F5D4B3F-5D61-4525-8C84-B8873AA3619AQ37129099-070699B7-7F69-41F5-9A3C-2D7B5BE28252Q37552063-198AFF4C-73B8-4C4D-8D0C-22AC767CBC59Q37724896-B0BDFCE6-FCA5-4B85-A905-CBDF9AF3A1B6Q37848142-6F374658-8A4A-4771-AFB5-86A9D21970B0Q38417110-D7203036-65F9-4FA7-B6E1-4701FC5840ACQ39326279-4F251105-B024-49D3-8D7B-B7155523420FQ40456654-0A9FB259-199C-43E6-B6CA-277C25CF91B1Q40815545-58471092-BE69-47C3-B3C5-5948267BF209Q41891773-9BD8071E-2CAD-4EF8-954D-32FADFAE7F96Q47448340-9816503E-3E60-49E6-8000-96FC28766367Q47750759-7E63B7F9-BCF5-40C6-9F6A-DEAFE5B5D299Q48273359-704E52E4-3E86-404C-A250-F3F5C169C57FQ52655970-E9245A42-33D6-4A8D-A630-E9D4766EFF53Q53159003-7CF32B83-78DC-4137-806C-7F042AADB23CQ54090336-AD55DF4A-71CC-4A3A-ADA2-DAAB129AA488Q55110646-C1B218BA-D0FD-4F11-B472-997A547E71AC
P2860
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
@ast
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
@en
type
label
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
@ast
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
@en
prefLabel
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
@ast
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
@en
P2093
P2860
P1476
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
@en
P2093
Colleen M Brensinger
Hedi Schelleman
Sean Hennessy
Warren B Bilker
Yu-Xiao Yang
P2860
P304
P356
10.1016/J.AMJMED.2009.07.020
P407
P577
2010-02-01T00:00:00Z